Micropharmacology Beyond Target Expression: Mapping Barriers to Intra-Tumoral Drug Delivery

Cancer Research · Published 2026-08-05 · DOI 10.1158/0008-5472.can-26-3273

Authors (1)

Hartland W. Jackson

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Jackson, H. (2026). Micropharmacology Beyond Target Expression: Mapping Barriers to Intra-Tumoral Drug Delivery. Cancer Research. https://doi.org/10.1158/0008-5472.can-26-3273

Related articles

• PI3K Regulates Wild-type RAS Signaling to Confer Resistance to KRAS Inhibition · Cancer Research · 2025 · Same journal
• Serine Starvation Modulates mRNA Splicing through Translational Inhibition of SRSF Proteins · Cancer Research · 2026 · Same journal
• Single-Cell Analysis of Residual Esophageal Squamous Cell Carcinoma After Neoadjuvant Immunochemotherapy Reveals TFAM-Mediated Immunoregulation in Dendritic Cells · Cancer Research · 2026 · Same journal
• Histone Lactylation Mediated by circRNA-Facilitated FXR1 Phase Separation Promotes Colorectal Cancer Progression · Cancer Research · 2026 · Same journal
• Lactylation Orchestrates Immune Evasion in Gastric Cancer through KDM5B-Mediated Histone Demethylation · Cancer Research · 2026 · Same journal
• Matrix Stiffness-Encoded Mechanical Memory Maintains Proliferative Dominance in Metastatic Tumors · Cancer Research · 2026 · Same journal
• Non-kinase Orchestrated VEGFR2–ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy · Cancer Research · 2026 · Same journal
• Regression-Associated Macrophages Recruit Natural Killer Cells that Constrain Targeted Therapy Resistance. · Cancer Research · 2026 · Same journal
• Parallel 4-1BB Signaling in Dual DLL3/CD56-Targeting CAR-T Cells Triggers Adaptive Proliferation and Functional Persistence to Eradicate Small Cell Lung Cancer · Cancer Research · 2026 · Same journal
• A Selective CK1α Degrader Targets Acute Myeloid Leukemia and Spares Normal Hematopoietic Cells · Cancer Research · 2026 · Same journal